ArticleCost effectiveness and resource allocation : C/E2026
Cost-utility analysis of home mechanical ventilation compared to hospital settings in patients with chronic obstructive pulmonary disease.
Article in Cost effectiveness and resource allocation : C/E, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating Disease Burden and Cost-Effectiveness for Value-Based Prioritisation of COPD Interventions: A Narrative Review.International journal of chronic obstructive pulmonary disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundChronic obstructive pulmonary disease is a chronic inflammatory disease that can be prevented and treated. The goals of therapy are to relieve symptoms, prevent disease progression, prevent exacerbations, improve general condition and physical performance, and reduce mortality. Mechanical ventilation is part of the standard treatment and can currently also be provided in the home environment. The aim of the study is to analyse the cost-effectiveness of home mechanical ventilation in adult patients with chronic obstructive pulmonary disease compared to facility-based mechanical ventilation from the perspective of a health care payer in the Czech Republic.
methodsA Markov model was used for the evaluation and its input parameters were obtained from the literature review and from the opinions of experts from home care and home mechanical ventilation companies. The cost-utility analysis was carried out over a time horizon of 10 years, including sensitivity analyses and multiple scenario analyses.
resultsThe cumulative costs per person of home mechanical ventilation are CZK 2,378,660 and the cumulative costs per person of the facility-based mechanical ventilation are CZK 5,793,883. The cumulative utilities per person of home mechanical ventilation are 1.20 QALY and the cumulative utilities per person of facility-based mechanical ventilation are 1.16 QALY. The incremental cost-utility ratio is -73,131,881 CZK/QALY. Sensitivity analyses and multiple scenario analyses showed no changes.
conclusionsHome mechanical ventilation was shown to be cost-effective for patients with chronic obstructive pulmonary disease, because it strongly dominates mechanical ventilation in a health care facility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.